HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
120,63
EUR
-6,92
EUR
-5,43
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 7,92% |
| Gilead Sciences Inc | US3755581036 | 6,07% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,26% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,12% |
| Amgen Inc | US0311621009 | 5,07% |
| Ascendis Pharma AS ADR | US04351P1012 | 4,22% |
| Axsome Therapeutics Inc | US05464T1043 | 3,79% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,44% |
| Merus NV | NL0011606264 | 3,42% |
| Arcutis Biotherapeutics Inc Ordinary Shares | US03969K1088 | 3,39% |
| Sonstige | 52,29% |